BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30112957)

  • 1. Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia.
    Woollacott IOC; Bocchetta M; Sudre CH; Ridha BH; Strand C; Courtney R; Ourselin S; Cardoso MJ; Warren JD; Rossor MN; Revesz T; Fox NC; Holton JL; Lashley T; Rohrer JD
    Neurocase; 2018 Jun; 24(3):166-174. PubMed ID: 30112957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
    Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities are seen only in
    Sudre CH; Bocchetta M; Cash D; Thomas DL; Woollacott I; Dick KM; van Swieten J; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Laforce R; Finger E; de Mendonça A; Sorbi S; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2017; 15():171-180. PubMed ID: 28529873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD.
    Wu Y; Shao W; Todd TW; Tong J; Yue M; Koga S; Castanedes-Casey M; Librero AL; Lee CW; Mackenzie IR; Dickson DW; Zhang YJ; Petrucelli L; Prudencio M
    Cell Rep; 2021 Aug; 36(8):109581. PubMed ID: 34433069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease.
    Huynh K; Piguet O; Kwok J; Dobson-Stone C; Halliday GM; Hodges JR; Landin-Romero R
    Neurology; 2021 Mar; 96(13):e1743-e1754. PubMed ID: 33597290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.
    Arrant AE; Onyilo VC; Unger DE; Roberson ED
    J Neurosci; 2018 Feb; 38(9):2341-2358. PubMed ID: 29378861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical White Matter Hyperintensities Markedly Impact Plasma Neurofilament Light Chain Variability in GRN Patients.
    Vítor J; Saracino D; Ströer S; Camuzat A; Dorgham K; Clot F; Martin-Hardy P; Pasquier F; ; Le Ber I
    J Alzheimers Dis; 2023; 94(4):1351-1360. PubMed ID: 37393503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations.
    Paternicò D; Premi E; Gazzina S; Cosseddu M; Alberici A; Archetti S; Cotelli MS; Micheli A; Turla M; Gasparotti R; Padovani A; Borroni B
    Neurobiol Aging; 2016 Feb; 38():176-180. PubMed ID: 26827655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia.
    Jiskoot LC; Panman JL; Meeter LH; Dopper EGP; Donker Kaat L; Franzen S; van der Ende EL; van Minkelen R; Rombouts SARB; Papma JM; van Swieten JC
    Brain; 2019 Jan; 142(1):193-208. PubMed ID: 30508042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers.
    Olm CA; McMillan CT; Irwin DJ; Van Deerlin VM; Cook PA; Gee JC; Grossman M
    Neuroimage Clin; 2018; 19():497-506. PubMed ID: 29984158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the cascade of biomarker changes in
    Panman JL; Venkatraghavan V; van der Ende EL; Steketee RME; Jiskoot LC; Poos JM; Dopper EGP; Meeter LHH; Donker Kaat L; Rombouts SARB; Vernooij MW; Kievit AJA; Premi E; Cosseddu M; Bonomi E; Olives J; Rohrer JD; Sánchez-Valle R; Borroni B; Bron EE; Van Swieten JC; Papma JM; Klein S;
    J Neurol Neurosurg Psychiatry; 2021 May; 92(5):494-501. PubMed ID: 33452053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations.
    Marian OC; Teo JD; Lee JY; Song H; Kwok JB; Landin-Romero R; Halliday G; Don AS
    Acta Neuropathol Commun; 2023 Mar; 11(1):52. PubMed ID: 36967384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    Feis RA; Bouts MJRJ; Dopper EGP; Filippini N; Heise V; Trachtenberg AJ; van Swieten JC; van Buchem MA; van der Grond J; Mackay CE; Rombouts SARB
    BMC Neurol; 2019 Dec; 19(1):343. PubMed ID: 31881858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.
    Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM
    Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.
    Filiano AJ; Martens LH; Young AH; Warmus BA; Zhou P; Diaz-Ramirez G; Jiao J; Zhang Z; Huang EJ; Gao FB; Farese RV; Roberson ED
    J Neurosci; 2013 Mar; 33(12):5352-61. PubMed ID: 23516300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.
    Arrant AE; Roth JR; Boyle NR; Kashyap SN; Hoffmann MQ; Murchison CF; Ramos EM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Roberson ED
    Acta Neuropathol Commun; 2019 Dec; 7(1):218. PubMed ID: 31870439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin.
    Caroppo P; Le Ber I; Camuzat A; Clot F; Naccache L; Lamari F; De Septenville A; Bertrand A; Belliard S; Hannequin D; Colliot O; Brice A
    JAMA Neurol; 2014 Dec; 71(12):1562-6. PubMed ID: 25317628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms.
    Huin V; Barbier M; Bottani A; Lobrinus JA; Clot F; Lamari F; Chat L; Rucheton B; Fluchère F; Auvin S; Myers P; Gelot A; Camuzat A; Caillaud C; Jornéa L; Forlani S; Saracino D; Duyckaerts C; Brice A; Durr A; Le Ber I
    Brain; 2020 Jan; 143(1):303-319. PubMed ID: 31855245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal Dominant Frontotemporal Lobar Degeneration in a Filipino Family with Progranulin Mutation.
    Dominguez J; Ng A; Yu J; Guevarra AC; Daroy ML; Alfon A; Catindig JA; Dizon M; Santiago J; Del Moral MC; Yu J; Jamerlan A; Ligsay A; Bagyinszky E; An SS; Kim S
    Dement Geriatr Cogn Disord; 2020; 49(6):557-564. PubMed ID: 33486486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers.
    Lee SE; Sias AC; Kosik EL; Flagan TM; Deng J; Chu SA; Brown JA; Vidovszky AA; Ramos EM; Gorno-Tempini ML; Karydas AM; Coppola G; Geschwind DH; Rademakers R; Boeve BF; Boxer AL; Rosen HJ; Miller BL; Seeley WW
    Neuroimage Clin; 2019; 22():101751. PubMed ID: 30921613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.